Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor News Updates.
Press releases published on September 5, 2025
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy
GlobeNewswire
·
September 5, 2025
SAXONBURG, Pa., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announced today its membership in the Diode Technology Working Group within the STARFIRE Hub, a collaborative initiative led by Lawrence Livermore …
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
GlobeNewswire
·
September 5, 2025
SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
Fundamental Global Inc. Amends its Charter with the State of Nevada
GlobeNewswire
·
September 5, 2025
Certificate of Amendment Changes Name to FG Nexus Inc., Increases Authorized Shares, Triggers Conversion of Automatic Exercise Pre-Funded Warrants to Common Stock and Expands Outstanding Share Count to Over 35 million Charlotte, NC, Sept. 05, 2025 (GLOBE …
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
GSR IV Acquisition Corp. Announces the Closing of its $230 Million Initial Public Offering, Including Full-Exercise Of Over-Allotment Option
GlobeNewswire
·
September 5, 2025
New York, NY, Sept. 05, 2025 (GLOBE NEWSWIRE) -- GSR IV Acquisition Corp. (NASDAQ: GSRF) (“GSRF” or the “Company”) announced today that it closed its initial public offering of 23,000,000 units at a price of $10.00 per unit, for aggregate gross proceeds of …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2025 the Company granted inducement awards to …
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …
Shaping Wealth and Sherpas Partner to Make AI-Driven Financial Advice More Human
EIN Presswire
·
September 5, 2025
The partnership integrates Shaping Wealth’s Lydia™ into Sherpas’ AI agent infrastructure, bringing behavioral intelligence directly into the advisor workflow CHICAGO, IL, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Shaping Wealth, the leading …
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants
GlobeNewswire
·
September 5, 2025
REHOVOT, Israel, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, …
Spring Valley Acquisition Corp. III Announces Closing of $230 Million Initial Public Offering
GlobeNewswire
·
September 5, 2025
DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Spring Valley Acquisition Corp. III (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business …
Aristotle Receives CFTC Approval for DCM and DCO, Paving the Way for New U.S. Prediction Market Exchange
GlobeNewswire
·
September 5, 2025
WASHINGTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Aristotle, the company that services PredictIt, today announced that the Commodity Futures Trading Commission (CFTC) has approved its applications to operate as both a Designated Contract Market (DCM) and a …
Blink Charging President and CEO, Mike Battaglia, to Present at the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9, 2025
GlobeNewswire
·
September 5, 2025
Bowie, MD, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK), a leading global owner, operator, provider of electric vehicle (EV) charging equipment and services, today announced that Mike Battaglia, President and CEO, will present at …
DIAGNOS Announces Closing of Private Placement
GlobeNewswire
·
September 5, 2025
BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial …
Pixalate Releases Q2 2025 Global Connected TV (CTV) Ad Supply Chain Trends Reports: Open Programmatic Ad Spend at $5.7 Billion While Ad Fraud (IVT) Remained at 18%
GlobeNewswire
·
September 5, 2025
LONDON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the Q2 2025 Global Connected TV (CTV) Ad Supply Chain Trends Report. The report comprehensively analyzes the …
U.S. Global Investors Announces Fiscal 2025 Webcast
GlobeNewswire
·
September 5, 2025
San Antonio, TX, Sept. 05, 2025 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (Nasdaq: GROW) will host a webcast on Tuesday, September 9, at 7:30 a.m. Central time to discuss the company’s results for fiscal year 2025. Financial data for the fiscal year …
Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman
GlobeNewswire
·
September 5, 2025
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into freefall. A newly filed securities class action accuses the biotech firm and …